
Arvikha Pharmaceuticals Private Limited
About Arvikha Pharmaceuticals Private Limited
Data last updated:
Arvikha Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India, recognised as a startup by DPIIT. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 15 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24299WB2021PTC242582.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Harshit Garg and Shikha Garg.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 71 Canning Street, Kolkata, West Bengal, India – 700001.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.09 Lakh, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹3.86 Lakh (net margin 20.2%) and EBITDA of ₹4.21 Lakh (EBITDA margin 22%). Revenue has declined at a compounded annual rate (CAGR) of 15% over three years.
Arvikha Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0013785).
Company details
Recognitions & Rankings of Arvikha Pharmaceuticals
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-WB-10-0013785
Contact details
Arvikha Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal.
- Registered Address71 Canning Street, Kolkata, West Bengal, India – 700001
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Arvikha Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Arvikha Pharmaceuticals Private Limited, buy the company report.
Financials of Arvikha Pharmaceuticals Private Limited
FY 2025 filings availableArvikha Pharmaceuticals Private Limited reported revenue of ₹19.09 Lakh (up 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 15% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 15%. EBITDA rose 230% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.21 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.86 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22% | ||||
| Net Profit Margin | 20.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Arvikha Pharmaceuticals Private Limited, buy the company report.
Board of directors of Arvikha Pharmaceuticals Private Limited
Arvikha Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harshit Garg | Director | 15 Jan 2021 | 5 Years 10 Months | Current |
| Shikha Garg | Director | 15 Jan 2021 | 5 Years 10 Months | Current |
Peer comparison
Arvikha Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ado Pharmaceuticals Private Limited | ₹19.12 Lakh (FY 2024) | 47.0% | Mohali, Punjab, India | |||
| Arvikha Pharmaceuticals Private Limitedthis company | ₹19.09 Lakh (FY 2025) | ₹3.86 Lakh | 20.2% | 15.0% | Kolkata, West Bengal, India | |
| Dablap Pharmaceuticals Private Limited | ₹19.07 Lakh (FY 2025) | 38.0% | Delhi, India | |||
| Eligens Pharmaceuticals Private Limited | ₹19.06 Lakh (FY 2025) | 29.0% | Lucknow, Uttar Pradesh, India | |||
| Pinakin Pharmaceuticals Private Limited | ₹19.03 Lakh (FY 2024) | 3.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Arvikha Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Arvikha Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Arvikha Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Arvikha Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Arvikha Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Harshit Garg was appointed as Director on 15 Jan 2021.
Frequently asked questions
Arvikha Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 15 January 2021 (5+ years old) and is registered under CIN U24299WB2021PTC242582.
Arvikha Pharmaceuticals has 2 current directors:
- Harshit Garg - Director
- Shikha Garg - Director
The latest financial statements of Arvikha Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Arvikha Pharmaceuticals is U24299WB2021PTC242582. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arvikha Pharmaceuticals was incorporated on 15 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Arvikha Pharmaceuticals by revenue are Ado Pharmaceuticals Private Limited, Dablap Pharmaceuticals Private Limited, Eligens Pharmaceuticals Private Limited, Pinakin Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Harshit Garg was appointed as Director on 15 Jan 2021. Shikha Garg was appointed as Director on 15 Jan 2021.
Yes, Arvikha Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Arvikha Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-10-0013785).
The registered office of Arvikha Pharmaceuticals is at 71 Canning Street, Kolkata, West Bengal, India – 700001.
Arvikha Pharmaceuticals operates in the chemicals industry, in the fine chemicals and other chemical products segment.

